Mount Sinai Receives Award from VNSNY CHOICE SelectHealth

From left: Matthew Baney with Michael Mullen, MD, Director, Institute for Advanced Medicine, Mount Sinai Health System; Thomas Dwyer, Senior Vice President, Visiting Nurse Service of New York; and Edward Lucy, Chief Administrative and Contracting Officer, Mount Sinai Health System.

VNSNY CHOICE SelectHealth, a New York State Department of Health Special Needs Plan for Medicaid-eligible New Yorkers living with HIV, recently awarded the Mount Sinai Health System $360,000 for its efforts at successfully improving the overall health status of its members.

Mount Sinai’s Institute for Advanced Medicine, which directs all of the Mount Sinai Health System’s HIV prevention and treatment programs, serves more than 1,100 HIV-positive VNSNY CHOICE SelectHealth members annually. The award will be used to support Mount Sinai’s quality initiatives that serve this population.

“VNSNY CHOICE SelectHealth shares with our Mount Sinai provider partners the conviction that HIV infection is now a readily treatable condition from which no New Yorker needs to suffer or die,” says Jay Dobkin, MD, Medical Director for VNSNY CHOICE SelectHealth. “We are gratified that our efforts in support of the Mount Sinai program have been so successful, and hope to build even more effective collaborations in the future.”

Matthew Baney, Senior Director of the Institute for Advanced Medicine, says, “We have been successful in starting and maintaining our patients on medications to keep them healthier. All of our sites have initiated outreach efforts and care coordination activities directed at finding patients who fall out of care and getting them back into treatment. We also have a fair amount of patients in the Mount Sinai Health Home Program, which is a free service that integrates and coordinates health care for people on Medicaid—and that has a significant impact on suppression rates.”

Mount Sinai Researcher Wins Young Investigator Award

Benjamin D. Greenbaum, PhD

Immunotherapy has been a game changer in treating some cancers, but it does not work for every patient. Building mathematical models that might predict a patient’s response is central to the work of Benjamin D. Greenbaum, PhD, Assistant Professor of Medicine (Hematology and Medical Oncology), Oncological Sciences, and Pathology, at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. For his efforts, he recently won the Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Dr. Greenbaum, a computational biologist, was among seven researchers to receive the award from the Pershing Square Sohn Cancer Research Alliance, a program of The Pershing Square Foundation. His laboratory will receive $200,000 yearly for the next three years. In a novel partnership, The Mark Foundation for Cancer Research will fully fund Dr. Greenbaum’s award, and has named him a Pershing Square Sohn Mark Foundation Fellow.

Dr. Greenbaum’s work “will be instrumental in understanding what types of T cells are required for generating effective anti-tumor immunity and how to design immune therapies that selectively induce their development,” says a longtime colleague and mentor, Nina Bhardwaj, MD, PhD, the Ward-Coleman Chair in Cancer Research, and Director of Cancer Immunotherapy, at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

Dr. Greenbaum began his career studying the evolution of viruses and later became interested in checkpoint blockade inhibitor immunotherapies, which help the body recognize and kill cancer cells, and for which the Nobel Prize was recently awarded. He led a group that created the first predictive mathematical model demonstrating how a set of melanoma and lung cancer patients would respond to certain immunotherapies, a finding described in November 2017 in the journal Nature. To further improve such models, “we work with clinicians, oncologists, immunologists, geneticists, and others to try to round out the full picture of how the immune system interacts with cancer,” Dr. Greenbaum says. “This is a very vibrant time in cancer immunotherapy.”

Harvard Business Review: How Mount Sinai Health System Fosters Collaboration to Fight Cancer

Samir Parekh, MD

In an article published in the Harvard Business Review, Joel Dudley, PhD, Mount Sinai Professor in Biomedical Data Science at the Icahn School of Medicine at Mount Sinai and Executive Vice President for Precision Health for the Mount Sinai Health System, and Samir Parekh, MD, Associate Professor, Medicine (Hematology and Medical Oncology), and Oncological Sciences, write about the unique partnership between researchers and doctors at Mount Sinai who are using advanced computer analytics to treat blood and bone marrow cancers.

Joel Dudley, PhD

“The Mount Sinai Health System is organized differently from most, as one integrated institution. Doctors from the seven Mount Sinai hospitals work side by side with researchers from the Icahn School of Medicine at Mount Sinai,” the authors write.

“Indeed, many clinicians also have Sinai research labs. If a clinician and a researcher devise a viable idea to solve a medical problem, they are free to join forces and pursue the project. This makes it possible to rapidly bring a finding from the lab bench to the patient bedside.”

Read the full article in the Harvard Business Review

Sixth Episode of Mount Sinai Future You

The sixth episode of Mount Sinai Future You highlights inspirational stories and features a young man’s journey following a horrific car accident that left him paralyzed. With the help of the exoskeleton program, Thomas Bryce, MD, Director of the Spinal Cord Injury Program at Mount Sinai, and Angela Riccobono, PhD, Senior Clinical Psychologist of Rehabilitation Medicine at Mount Sinai, he was able to participate in the 2018 New Balance 5th Avenue Mile Race sponsored by the New York Road Runners.

Mount Sinai Future You, which highlights innovation at Mount Sinai, is being broadcast on CUNY TV, the non-commercial educational-access cable channel run by The City University of New York.

Mount Sinai Future You takes viewers behind the scenes as doctors at Mount Sinai Health System leverage innovative science to change patients’ lives every day. The series  highlights preventative care and treatment models that will lead to better health and longer lives.

 Mount Sinai Future You, Episode Six, also features:

  • Keith J. Benkov, MD, Associate Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Kravis Children’s Hospital, and a patient with Crohn’s disease bond over their love of running.
  • Marla C. Dubinsky, MD, Chief of Pediatric Gastroenterology and Hepatology at Mount Sinai Kravis Children’s Hospital, dedicates her time to helping young patients with Crohn’s disease live comfortable and normal lives.
  • Lisa M. Satlin, MD, Chair of Pediatrics at Mount Sinai Kravis Children’s Hospital, and Jeffery M. Saland, MD, Chief of the Division of Pediatric Nephrology and Hypertension at Mount Sinai, diagnose an infant with a rare heart defect that would save her life with only minutes to spare.
  • Barry Love, MD, Assistant Professor in the Division of Cardiology in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine and Mount Sinai Kravis Children’s Hospital, uses a tiny, wireless pacemaker to help a teenager with a congenital heart condition continue his love of travel and adventure.
  • Harsha Reddy, MD, Oculoplastic Surgeon at New York Eye and Ear Infirmary of Mount Sinai, uses his delicate touch in the operating room to preserve a patient’s eyesight.
  • Carlos Cordon-Cardo, MD, PhD, Chairman of the Department of Pathology at the Mount Sinai Health System, and Gerardo Fernandez, MD, Director of Precise MD at the Icahn School of Medicine, use precision medicine to more accurately diagnosis prostate cancer.
  • This year marks the 50th anniversary of the Icahn School of Medicine. David L. Reich, MD, President and Chief Operating Officer of The Mount Sinai Hospital, shares his journey as an alumni of the school.

New episodes of Mount Sinai Future You will run during the first week of each month, rerunning on Wednesday, Thursday, and Saturday. You can find CUNY TV here:

  • Spectrum, Cablevision and Optimum Brooklyn: Channel 75
  • RCN Cable: Channel 77
  • Verizon FiOS: Channel 30

Kenneth L. Davis, MD, President and CEO of Mount Sinai, in LEADERS Magazine: Consistent Quality

In an interview with LEADERS magazine, Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, talks about the keys to Mount Sinai’s consistent strength and leadership in the industry, how the role of the hospital is evolving, and other current topics.

“The brand has always stood for consistent quality, even when faced with the most complex conditions. We continue to make that the highest priority as we take care of the sickest people, regardless of their backgrounds, and get the best possible outcomes,” Dr. Davis says in the interview. “Innovation goes hand-in-hand with that. Our innovation is fostered by the fact that our hospital gave birth to our medical school. The dean of the medical school doesn’t report to a university but to a health system. It’s easier to keep innovation at the forefront of the health system when there is a medical school right behind it.”

See the full interview in LEADERS magazine

Read the article [PDF]

Class of 2022 Takes Its Place in the Field of Medicine

Students celebrated at the White Coat Ceremony.

One hundred forty medical students who constitute the Icahn School of Medicine at Mount Sinai’s Class of 2022 were welcomed into the medical profession on Thursday, September 13, at the school’s symbolic White Coat Ceremony in Stern Auditorium. Surrounded by family members, alumni, and Mount Sinai Health System leaders, the students proudly received their white coats and recited an oath they had written to accept the privilege and responsibility being bestowed upon them as society’s future physicians.

Peter W. May, Chairman, Boards of Trustees, Mount Sinai Health System, told the audience that the medical school was unique in that it was founded 50 years ago by a hospital, rather than a large university. “What we care about is creating research that gets applied to the clinic as quickly as possible to help our patients,” he said. “You are receiving your white coats today because your clinical training starts right at the beginning of your medical education. At Mount Sinai, you will have the opportunity to learn and work with brilliant professors in math, computer science, engineering, and the physical sciences. This interdisciplinary collaboration extends the boundaries of what modern medicine can achieve.”

Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, encouraged the students to take the time to explore the many research and clinical opportunities the school has to offer in order to find an area of medicine they love. He said Mount Sinai’s commitment to helping students find their passion is the same as it was nearly 50 years ago, when he entered the school’s second class.

During the ceremony, students Dillan Villavisanis, left, and Vivek Vishwanath received their white coats from Medical Education Faculty Advisors Olanrewaju Dokun, MD, left, and Caroline Cromwell, MD.

“You have earned the right to be here. You have the capacity to be great,” Dr. Davis told the students. “Let today be remembered as the day you committed to achieve that greatness by searching for that part of this worthy profession that lights an unquenchable fire in you. That takes time.”

Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, said the high academic achievements, skills, and interests among the Class of 2022 were evidence of their potential to become the “next generation of brilliant physicians, transformative scientists, and leaders who will shape the future of education, biomedical research, and delivery of high quality care to all Americans.”

Dr. Charney said the ability to change the field of medicine would belong to only a talented few, including the Class of 2022. This, he said, brought to mind the famous 1940 speech by the British Prime Minister Winston Churchill, who said of the Royal Air Force during the Battle of Britain, “Never in the field of human conflict was so much owed by so many to so few.”

The white coat, said Dr. Charney, comes with “serious responsibilities. Patients will ask you for answers, and sometimes the answers are not forthcoming. Class of 2022, there are only 140 of you, yet there are so many patients in our local community, our city, our country, our world who are going to need you.”

On the occasion of its 50th anniversary this year, the Icahn School of Medicine inaugurated the first Hans Popper, MD, PhD, Keynote Speaker at the White Coat Ceremony, and extended this honor to 2009 Mount Sinai alumnus Pooja Mehta, MD, MSHP, Assistant Professor, Obstetrics and Gynecology at Louisiana State University School of Medicine. Dr. Mehta also serves as Director of Women’s Health Policy and interim Chief Medical Officer of Medicaid for the state of Louisiana.

Dr. Mehta relayed the story of a very ill woman she once treated who taught her how important it is to understand the patient. She said, this woman—whose tragic health outcome was largely preventable—ultimately led her to Louisiana where she cares for underserved women, as well as transgender and gender non-conforming individuals, “who seek self-determination in health care.”

“You will have all the tools you need when you leave here to question, to think critically, to evaluate evidence, to work in a hospital, and to work outside the four walls of a hospital,” said Dr. Mehta. “Use every drop of privilege this white coat gives you. But don’t wait too long to divest from your privilege to meet the people where they are, and—as stated in the Oath of Maimonides that I took in this room 14 years ago—to be a fellow creature in pain.”